Yes Cake, this stock is definitely frustrating. I remember...

Yes Cake, this stock is definitely frustrating.

I remember (vaguely) that before we got Fonda approved, there were valuations of well over $1 for the stock, just for the Fonda component. Now we sit <60c and we have the HA-I as the added benefit. My question, has the correct value already been added in and, like when Fonda was approved, we LT'ers end up with a sad surprise?

And Titus, if the trial is truly double blind, how could the CEO truly say anything with confidence? Maybe it is just wishful thinking like us holders?

I lightened a little when the price was hovering in the 60's and high 50's, but still hold enough and close to free carried. If it drops more (I doubt it, but have been surprised before) I will buy back in.

All the very best, Mop.